We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cell/Gene Therapies’ Unique Attributes Set Them Apart, Say Comments on Draft Guidance
Cell/Gene Therapies’ Unique Attributes Set Them Apart, Say Comments on Draft Guidance
Comments filed on the FDA’s proposed guidance on potency assurance for cellular and gene therapy (CGT) products reflect the intricacies that set these treatments apart from drug interventions.